Shifting of Intrauterine Device and Use of the Menstrual Cup: Case-control Study
CUP-DIU
1 other identifier
observational
740
1 country
1
Brief Summary
In France, 26% of women of childbearing age use an intrauterine device (IUD) containing copper or levonorgestrel as a method of contraception. Failures of IUD contraception are mainly due to shifting or expulsion of the IUD. The risk factors for expulsion of IUDs most often found in the literature are young age (\<25 years), the existence of menorrhagia, dysmenorrhea, being a carrier of a copper IUD rather than a levonorgestrel IUD , a history of IUD expulsion, nulliparity, and an anomaly of the uterine cavity unrecognized (fibroma, adenomyosis). More and more women are turning to menstrual cups (MCs) as a means of periodic protection. But the use of MC has also been mentioned as a risk factor for IUD expulsion (via a suction effect). In May 2013, reports of displacement, rupture, or even expulsion of copper IUDs in CM users were reported to ANSM. However, few studies have examined the risks associated with the concomitant use of an MC and an IUD. The data are contradictory and insufficient to provide a clear answer to women. Hence the interest in carrying out a larger prospective study to explore the relationship between IUD expulsion and the use of MC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 18, 2020
CompletedFirst Submitted
Initial submission to the registry
January 13, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 17, 2021
CompletedJune 22, 2021
June 1, 2021
1.2 years
January 13, 2021
June 20, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluating the risk of IUD displacement in patients using menstrual cup
Transvaginal ultrasounds will be used to monitor the position of the intrauterine device in patients using a menstrual cup.
1 DAY
Study Arms (2)
CAS
TEMOIN
Interventions
Eligibility Criteria
Patients with an intrauterine device for contraception.
You may qualify if:
- Patient aged 18 or over
- Consultant for one of the following reasons:
- IUD control
- IUD expulsion
- Pregnancy on IUD
- Other reason that required an ultrasound for the IUD
- Consent to participate in the study
You may not qualify if:
- Patient benefiting from a legal protection measure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
cabinet IPSO
Paris, 75003, France
Related Publications (1)
Claire J, Mir S, Dumortier I, Liard R, Yavchitz A, Le Cossec C, Picard H. The use of a menstrual cup as a risk factor for displacement of intrauterine devices: a case-control study. Contracept Reprod Med. 2025 May 6;10(1):33. doi: 10.1186/s40834-025-00366-3.
PMID: 40329407DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2021
First Posted
March 4, 2021
Study Start
March 18, 2020
Primary Completion
May 17, 2021
Study Completion
May 17, 2021
Last Updated
June 22, 2021
Record last verified: 2021-06